Implantable Cardioverter Defibrillators. Antiarrhythmic drugs and separate bradycardia
pacing systems are prescribed commonly in patients with implantable cardioverter …

Objectives: The purpose of this study was to evaluate an implantable cardioverter-
defibrillator (ICD) incorporating biventricular pacing. Background: Biventricular pacing …

Concomitant use of a pacemaker and an automatic implantable cardioverter-defibrillator
(AICD) is common. Seventeen percent of patients receiving an AICD at The Johns Hopkins …

Nonpharmacologic therapy for ventricular arrhythmias has gained growing attention with the
development of the implantable cardioverter-defibrillator. In addition, the reports of adverse …

Objectives. The purpose of this study was to identify the causes of oversensing during
ventricular pacing in patients with a thirdgeneration implantable cardioverter-defibrillator …

Objectives. This study evaluates the ability of a third-generation cardioverter-defibrillator to
abort energy delivery and the importance of electrogram storage in analyzing the aborted …

Objectives: The purpose of this study was to determine the least expensive strategy for
device selection in patients receiving implantable cardioverter-defibrillators (ICDs) …

The aim of the article was to provide an overview of published studies regarding the
electromagnetic compatibility (EMC) of electronic implants. The available literature was …

Ten consecutive patients (mean age 57.9±7.6 years) were treated with an investigational
tachyarrhythmia control device, the implantable Medtronic Pacer‐, Cardioverter …

Abstract In 17 patients (14 men and 3 women aged 69±10 years), a transvenous pacemaker
was implanted before (8 patients), following (7 patients), or simultaneously (2 patients) with …